(Press-News.org) TORONTO, Canada -- Scientists at the Princess Margaret Cancer Centre have discovered a function of the tumor suppressor gene PTEN that helps explain why certain promising therapies fail in many cancer patients, a finding that could aid in delivering tailored, personalized cancer medicine based on an individual's genetics.
The research, published online today in Science, "increases understanding of the molecular mechanisms of action of PTEN, which is known to be defective in as many as half of all advanced cancers" says principal investigator Vuk Stambolic, Senior Scientist at the Princess Margaret Cancer Centre. Dr. Stambolic, a specialist in cell signalling, is also an Associate Professor in the Department of Medical Biophysics, University of Toronto.
In the lab, working with cell and animal models of cancer, the research team discovered what happens when the protein product of PTEN is lost or deregulated. Dr. Stambolic says: "We realized that the PTEN nuclear function links this tumor suppressor to the response to conventional cancer treatments, such as chemotherapy or radiation. This new knowledge, combined with our prior understanding of PTEN, provided immediate clues for individualizing therapy for patients with PTEN-deficient tumors."
Medical oncologist Lillian Siu, who leads numerous clinical trials at Princess Margaret, but was not directly involved in this research, says: "For clinicians, this is a significant finding that could help guide treatment decisions, especially considering that we can already test for PTEN deficiency by molecularly analyzing biopsied tissue, providing a biomarker for implementation of combined therapies that may be most effective."
For Dr. Stambolic, the discovery builds on his earlier research (Cell, 1998) which helped explain how PTEN loss promotes cell survival, another key feature of cancerous cells. "We now realize that the PTEN story was only half-told in 1998," says Dr. Stambolic. "The new findings, in conjunction with advances in molecular profiling and access to drugs already available or being tested in clinical development, present a tangible scenario to tailor treatment."
INFORMATION:
The research was funded by the Canadian Cancer Society, the Canadian Institutes of Health Research, the Ontario Ministry of Health and Long-term Care and The Princess Margaret Cancer Foundation.
About the Princess Margaret Cancer Centre, University Health Network
The Princess Margaret Cancer Centre has achieved an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is a member of the University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital and Toronto Rehabilitation Institute. All are research hospitals affiliated with the University of Toronto. For more information, go to http://www.theprincessmargaret.ca or http://www.uhn.ca.
Media contact
Jane Finlayson
Senior Public Affairs Advisor
Princess Margaret Cancer Centre
University Health Network
Phone: 416-946-2846
Email: jane.finlayson@uhn.ca
Cancer researchers PTEN discovery provides knowledge to individualize treatment
2013-07-26
ELSE PRESS RELEASES FROM THIS DATE:
False memories incepted into mouse brain shed light on neural basis of human phenomenon
2013-07-26
Researchers at the RIKEN-MIT Center for Neural Circuit Genetics and MIT's Picower Institute for Learning and Memory have implanted false memories into mice, potentially illuminating the mechanisms underlying the human phenomenon of "recalling" experiences that never occurred.
In previous work, the researchers had detected a single memory in the brain, genetically tagged the brain cells housing that memory with a light-sensitive protein, and flickered pulses of light to "turn on" the memory at any given moment. The latest work, to be reported in the journal Science, tinkers ...
Women's height linked to cancer risk
2013-07-26
PHILADELPHIA — The taller a postmenopausal woman is, the greater her risk for developing cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Height was linked to cancers of the breast, colon, endometrium, kidney, ovary, rectum, and thyroid, as well as to multiple myeloma and melanoma, and these associations did not change even after adjusting for factors known to influence these cancers, in this study of 20,928 postmenopausal women, identified from a large cohort of 144,701 ...
Delay in seeking stroke care costs women best treatment
2013-07-26
Women with clot-caused strokes are less likely than men to arrive at the hospital in time to receive the best treatment, according to a European study reported in the American Heart Association journal Stroke.
In the study, 11 percent of women with acute ischemic strokes were treated with the clot-dissolving medication alteplase, compared with 14 percent of men. Study participants included 5,515 patients at 12 hospitals in the Netherlands.
Researchers found no gender gap when they looked only at patients who arrived at the hospital within four hours of the onset of symptoms ...
Technology/equipment issues account for almost 1 in 4 operating room errors
2013-07-26
Around a quarter of all operating room errors are caused by technology/equipment problems, indicates an analysis of the available evidence, published online in BMJ Quality & Safety.
Inability to use the technology/equipment, lack of availability, and faulty devices/machines made up the bulk of the problems, the analysis indicates.
The researchers methodically searched for published studies on errors and problems arising in operating rooms in electronic databases. After applying a quality assessment technique, they found 28 studies out of a total of 19,362 pieces of ...
Certain blood pressure drugs slow dementia deterioration
2013-07-26
A class of drug, called ACE inhibitors, which are used to lower blood pressure, slow the rate of cognitive decline typical of dementia, suggests research published in the online journal BMJ Open.
Furthermore, these drugs may even boost brain power, the research indicates.
The researchers compared the rates of cognitive decline in 361 patients who had either been diagnosed with Alzheimer's disease, vascular dementia, or a mix of both.
Eighty five of the patients were already taking ACE inhibitors; the rest were not.
The researchers also assessed the impact of ACE ...
Analysis of 26 networked autism genes suggests functional role in the cerebellum
2013-07-26
Cold Spring Harbor, NY – A team of scientists has obtained intriguing insights into two groups of autism candidate genes in the mammalian brain that new evidence suggests are functionally and spatially related. The newly published analysis identifies two networked groupings from 26 genes associated with autism that are overexpressed in the cerebellar cortex, in areas dominated by neurons called granule cells.
The team, composed of neuroscientists and computational biologists, worked from a database providing expression levels of individual genes throughout the mouse ...
Boston Children's researchers observe new mechanism for diabetes resolution
2013-07-26
Boston, Mass., July 25, 2013 – Though existing research has shown gastric bypass surgery resolves type 2 diabetes, the reason has remained unclear. A research team, led by Nicholas Stylopoulos, MD, Boston Children's Hospital's Division of Endocrinology, has identified the small intestine—widely believed to be a passive organ—as the major contributor to the body's metabolism, based on a study in rats. The report will appear in Science on July 26, 2013.
Weight loss and improved diabetes often go hand-in-hand, but type 2 diabetes often gets resolved even before weight loss ...
Scientists model 'extraordinary' performance of Bolt
2013-07-26
As the world's best athletes descend on London today to take part in the Olympic Anniversary Games, a group of researchers from Mexico has provided an insight into the physics of one of the greatest athletic performances of all time.
In a new paper published today, 26 July, in IOP Publishing's European Journal of Physics, the researchers have put forward a mathematical model that accurately depicts the truly extraordinary feats of Usain Bolt during his 100 metre world record sprint at the 2009 World Championships in Berlin.
According to the researchers' model, Bolt's ...
Broad-scale genome tinkering with help of an RNA guide
2013-07-26
DURHAM, N.C. -- Duke researchers have devised a way to quickly and easily target and tinker with any gene in the human genome. The new tool, which builds on an RNA-guided enzyme they borrowed from bacteria, is being made freely available to researchers who may now apply it to the next round of genome discovery.
The new method also has obvious utility for gene therapy and for efforts to reprogram stem or adult cells into other cell types – for example, to make new neurons from skin cells.
"We have the genome sequence and we know what all the parts are, but we are ...
MIT neuroscientists show ability to plant false memories
2013-07-26
CAMBRIDGE, MA -- The phenomenon of false memory has been well-documented: In many court cases, defendants have been found guilty based on testimony from witnesses and victims who were sure of their recollections, but DNA evidence later overturned the conviction.
In a step toward understanding how these faulty memories arise, MIT neuroscientists have shown that they can plant false memories in the brains of mice. They also found that many of the neurological traces of these memories are identical in nature to those of authentic memories.
"Whether it's a false or genuine ...